These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2974264)

  • 1. Mesocortical dopaminergic function and human cognition.
    Weinberger DR; Berman KF; Chase TN
    Ann N Y Acad Sci; 1988; 537():330-8. PubMed ID: 2974264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of cortical function in patients with Parkinson's disease.
    Mattay VS; Tessitore A; Callicott JH; Bertolino A; Goldberg TE; Chase TN; Hyde TM; Weinberger DR
    Ann Neurol; 2002 Feb; 51(2):156-64. PubMed ID: 11835371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia.
    Weinberger DR; Berman KF; Daniel DG
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():568A-569A. PubMed ID: 1498953
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
    Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
    Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity.
    Berman KF; Illowsky BP; Weinberger DR
    Arch Gen Psychiatry; 1988 Jul; 45(7):616-22. PubMed ID: 3382321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia.
    Daniel DG; Weinberger DR; Jones DW; Zigun JR; Coppola R; Handel S; Bigelow LB; Goldberg TE; Berman KF; Kleinman JE
    J Neurosci; 1991 Jul; 11(7):1907-17. PubMed ID: 2066768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional imaging of cognition in Parkinson's disease.
    Carbon M; Marié RM
    Curr Opin Neurol; 2003 Aug; 16(4):475-80. PubMed ID: 12869806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.
    Weinberger DR; Berman KF; Illowsky BP
    Arch Gen Psychiatry; 1988 Jul; 45(7):609-15. PubMed ID: 3382320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral transplantation of dopamine neurons: understanding the functional role of the mesolimbocortical dopamine system and developing a therapy for Parkinson's disease.
    Brundin P; Strecker RE; Gage FH; Lindvall O; Björklund A
    Ann N Y Acad Sci; 1988; 537():148-60. PubMed ID: 3059921
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional mapping of dopaminergic transmission].
    Sawamoto N
    Rinsho Shinkeigaku; 2007 Nov; 47(11):832-4. PubMed ID: 18210810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional alpha-synuclein aggregation, dopaminergic dysregulation, and the development of drug-related visual hallucinations in Parkinson's disease.
    Papapetropoulos S
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):149-57. PubMed ID: 16720791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa--measurement by Xe-enhanced CT].
    Aiba I; Indo T; Takahashi A
    Rinsho Shinkeigaku; 1994 Nov; 34(11):1099-104. PubMed ID: 7729088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement.
    Monchi O; Petrides M; Mejia-Constain B; Strafella AP
    Brain; 2007 Jan; 130(Pt 1):233-44. PubMed ID: 17121746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
    Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
    Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial aspects of language and speech related to prefrontal cortical activity. A selective review.
    Ingvar DH
    Hum Neurobiol; 1983; 2(3):177-89. PubMed ID: 6365859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dopaminergic modulation of cerebral activity and cognitive functions].
    Jucaite A
    Medicina (Kaunas); 2002; 38(4):357-62. PubMed ID: 12474782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mesoprefrontal dopamine neurons in stress.
    Horger BA; Roth RH
    Crit Rev Neurobiol; 1996; 10(3-4):395-418. PubMed ID: 8978988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory processing in Parkinson's and Huntington's disease: investigations with 3D H(2)(15)O-PET.
    Boecker H; Ceballos-Baumann A; Bartenstein P; Weindl A; Siebner HR; Fassbender T; Munz F; Schwaiger M; Conrad B
    Brain; 1999 Sep; 122 ( Pt 9)():1651-65. PubMed ID: 10468505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal cortical blood flow and cognitive function in Huntington's disease.
    Weinberger DR; Berman KF; Iadarola M; Driesen N; Zec RF
    J Neurol Neurosurg Psychiatry; 1988 Jan; 51(1):94-104. PubMed ID: 2965218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and the neural circuitry of primate prefrontal cortex: implications for schizophrenia research.
    Lewis DA; Hayes TL; Lund JS; Oeth KM
    Neuropsychopharmacology; 1992 Feb; 6(2):127-34. PubMed ID: 1610486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.